Clinical trials
Gynecological Cancer clinical trials
Below are recruiting gynecological cancer clinical trials, each written for real people, not researchers. We’re tracking 178 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04063527RecruitingPhase 3
Stage I ovarian cancer treatment after surgery
This trial studies whether an additional treatment after surgery can help people with early-stage epithelial ovarian cancer live longer and stay well for more time. It is meant for patients who had a detailed staging operation and are able to start treatment within 8 weeks.
Nagakute-shi, Aichi-kenAges 20 years+ - NCT07169396Recruiting
Genetic study for ovarian cancer treatments
This study looks at genetic changes in ovarian cancer to find possible targeted treatments. It may help you if you have certain types of ovarian cancer and are seeking more personalized care.
Reggio EmiliaAges 18 years+ - NCT07447895Recruiting
early pelvic floor therapy for women having pelvic radiation
This study tests whether starting pelvic floor physical therapy early can help women with cervical cancer who are receiving radiation and chemotherapy. It aims to improve quality of life by addressing muscle-related side effects of treatment.
Cincinnati, OhioAges 18 years+ - NCT07196033Recruiting
Cervical cancer brachytherapy registry study
This study collects information from patients with cervical cancer who are receiving standard treatment with chemotherapy, radiation, and brachytherapy (a type of internal radiation). The goal is to learn more about how this treatment works in a real-world setting to improve care for future patients.
Mumbai, MaharashtraAges Any age - NCT06632431Recruiting
Endometrial cancer study comparing old and new staging systems
This study looks at tissue samples and medical records of people with endometrial cancer who had surgery between 2018 and 2022. It aims to compare older and newer ways of describing the cancer stage to help improve treatment decisions.
AsyutAges 18 years+ - NCT07407647RecruitingPhase 2
Vaginal DHEA for better vaginal health after pelvic radiation
This study tests whether a vaginal insert of DHEA (a hormone) can help with vaginal health problems caused by pelvic radiation for anal, rectal, or gynecologic cancers. It is for women who are already postmenopausal and are about to start radiation.
Columbus, OhioAges 50 years+ - NCT04655066Recruiting
Questionnaire study for pelvic floor symptoms during cancer treatment
This study asks people with breast or gynecologic cancer who are receiving cancer treatment to complete a validated questionnaire about how their pelvic floor feels. The goal is to better understand pelvic floor function and symptoms during systemic (whole-body) cancer therapy, which may help future care.
WiesbadenAges 18 years+ - NCT06781151Recruiting
Personalized treatment for recurrent gynecologic cancers
This study tests if personalized treatment plans, based on detailed genetic testing of your tumor, can help women with recurrent ovarian, cervical, or endometrial cancer. You will work with a team of specialists to find the best options for you.
Guangzhou, GuangdongAges 18 years+ - NCT07389863Recruiting
Sexual health after rectal cancer treatment
This study looks at the long-term effects of rectal cancer treatment on gynecological and sexual health. It aims to understand how women recover after treatment, helping improve future care and support.
RouenAges 18–60 - NCT04061967Recruiting
Reminder and self-sampling to help cervical screening
This study tests whether reminders and providing an at-home sample kit can help more women complete cervical cancer screening. It may help people who have not had follow-up after a prior abnormal result or who haven’t been screened in many years.
Luleå, Norrbotten CountyAges 33–75 - NCT07130240RecruitingPhase 2
Ivonescimab with chemo before surgery for cervical cancer
This trial tests adding a new drug called Ivonescimab to standard chemotherapy (paclitaxel and cisplatin) given before a hysterectomy in women with cervical cancer stage IB2 or IIA1 (tumor size 2-4 cm). The goal is to see if this combination improves outcomes compared to chemo alone.
ShanghaiAges 18–75 - NCT07101081Recruiting
HER2 in gynecologic cancers: a Brazilian study
This trial is looking at whether HER2, a protein linked to some cancers, is found in different gynecologic tumors. It tests stored tumor tissue from women in Brazil to learn more about this marker.
São PauloAges Any age - NCT06448897Recruiting
AI model to predict lymph node spread in cervical cancer
This study uses artificial intelligence to analyze your preoperative MRI and pathology results to better predict if cervical cancer has spread to pelvic lymph nodes. The goal is to improve future treatment decisions for patients with cervical cancer.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT06232213Recruiting
Personalized treatment for relapsed or drug-resistant gynecological cancers
This trial tests a personalized approach to treating advanced ovarian or endometrial cancers that have come back or stopped responding to standard treatments. It uses a special model to guide which therapy might work best for you.
Beijing, Beijing MunicipalityAges 18–80 - NCT07282158Recruiting
Coping help for ovarian cancer care providers
This trial tests a program to help doctors, nurses, and other clinicians who care for ovarian cancer patients manage burnout and stress. It aims to see if the adapted coping intervention improves well-being.
Seattle, WashingtonAges 18 years+ - NCT07261683RecruitingPhase 2
Combination therapy for recurrent ovarian cancer
This trial tests a new combination of chemotherapy, immunotherapy, and a bladder relaxant for ovarian cancer that has come back after initial treatment. It aims to see if adding these drugs together can help control the cancer longer.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT05236686Recruiting
Surgery to remove upper abdomen lymph nodes for ovarian cancer
This trial studies whether removing lymph nodes in the upper abdomen (hepatoceliac lymph nodes) improves outcomes for people with stage III or IV ovarian, fallopian tube, or primary peritoneal cancer that has spread to those lymph nodes. It also looks at how this surgery works for people with certain types of relapse, often alongside chemotherapy.
ShanghaiAges 18–75 - NCT04717349Recruiting
Study collects health information for kids’ and teens’ gynecology concerns
This is a research study that gathers information about pediatric and adolescent gynecology conditions. It may help researchers better understand these issues by learning about symptoms, care, and outcomes—without requiring a specific treatment.
Bethesda, MarylandAges 1 day–100 years - NCT07296237Recruiting
Women's sexual health after anal cancer radiation
This study looks at how women feel about their gynecological and sexual health after finishing radiation therapy for anal cancer. It may help doctors learn how to better support their patients after treatment.
AarhusAges 18 years+ - NCT07120529Recruiting
Comparing two types of hysterectomy for early cervical cancer
This study looks at two ways to remove the uterus and cervix for early-stage cervical cancer: minimally invasive surgery (like laparoscopic or robotic) versus open surgery (traditional large incision). It checks whether the less invasive approach works just as well in terms of survival and keeping the cancer from coming back.
BialystokAges 18–85 - NCT06796907RecruitingPhase 1/Phase 2
Mocertatug rezetecan with other drugs for advanced solid tumors
This trial tests a new drug, mocertatug rezetecan, combined with other anti-cancer therapies for people with advanced solid tumors like endometrial or ovarian cancer. It aims to see if the combination is safe and effective.
La Jolla, CaliforniaAges 18 years+ - NCT04989647RecruitingPhase 3
Stage IB1 to IIA cervical cancer surgery with possible radiation
This Phase 3 trial studies how best to treat intermediate-risk cervical cancer using radical surgery, with or without additional radiation after surgery. It may help find which approach lowers the chance the cancer comes back for patients with certain tumor risk features.
PragueAges 18–85 - NCT06878222RecruitingPhase 2
Testing an immunotherapy combo before surgery for cervical cancer
This trial tests whether combining two immunotherapy drugs (iparomlimab and tuvonralimab) with standard chemotherapy (paclitaxel and cisplatin) before surgery can help shrink cervical cancer. It is for people with certain stages of cervical cancer who are candidates for surgery, including those who want to preserve their fertility.
ShanghaiAges 18–75 - NCT03983226RecruitingPhase 2
Surgery plus niraparib for returning ovarian cancer
This trial tests whether adding niraparib (a pill treatment that targets cancer cell DNA repair) after surgery can help people with ovarian cancer that has come back. It focuses on “platinum-sensitive” cases and tries to remove all visible tumor when possible.
Shanghai, Shanghai MunicipalityAges 18–75
Hear when a new Gynecological Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for gynecological cancer?
- Yes. Clin2 currently lists 178 recruiting gynecological cancer studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a gynecological cancer trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a gynecological cancer trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.